chimmitecan

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2013
0120072013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Aim:To investigate the pharmacokinetics and disposition of simmitecan (L-P) that was a water-soluble ester prodrug of chimmitecan… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Receptor-interacting protein 3 (RIP3) is a serine/threonine protein kinase, which has extensive substrates including its cognate… (More)
  • figure 1
Is this relevant?
2011
2011
Simmitecan (L-P) is an anticancer ester prodrug, which involves activation to chimmitecan (L-2-Z). In the current study, a liquid… (More)
Is this relevant?
2008
2008
Camptothecins (CPT) activate S or G(2)-M arrest and the homologous recombination (HR) repair pathway in tumor cells. In this… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
PURPOSE This study aimed to evaluate antitumor activities and pharmacologic profiles of chimmitecan, a novel 9-small-alkyl… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
  • figure 3
Is this relevant?